LAWRENCE, Mass., July 15, 2015 /PRNewswire/ -- NxStage Medical, Inc. (Nasdaq: NXTM) today announced the launch of new Spanish-language resources to improve accessibility of home hemodialysis (HHD) with the NxStage® System One™ for Spanish speaking dialysis patients. In addition to providing Spanish education and training materials, NxStage, a leading manufacturer of dialysis products, has expanded its full-service technical and customer support to include bilingual assistance.
Magda Castaneda, RN, BSN, CNN, HTC, owner and director of Utopia Health Career Center, hopes the new resources will encourage Spanish-speaking dialysis patients to consider at-home therapy. "In my 18 years as a dialysis nurse, seven of them in home hemodialysis, I can say that having educational materials and professional support in Spanish is huge progress for the Hispanic community in need of dialysis treatments."
"It is exciting to know that NxStage has training materials available in Spanish. NxStage's training materials were very easy to use and accelerated my ability to learn how to use the System One at home," stated Walfred Lopez, a NxStage patient.
"The percentage of dialysis patients for which Spanish is the first language is as high as 30 percent in the United States," said Joseph Turk, President of NxStage Medical. "We want to provide all patients with access to important resources to be successful with home hemodialysis. These expanded initiatives have the potential to really make an impact with both new and existing Hispanic patients."
For more information regarding NxStage's new Spanish-language resources please visit http://go.nxstage.com/hhdesp/
NxStage's expanded bilingual technical and customer support team is based at the Company's headquarters in Lawrence, MA and is available by calling 1-866-NXSTAGE (1-866-697-8243). Talk to your doctor to find out if home hemodialysis is right for you.
About the NxStage System One
The NxStage System One is the first and only truly portable hemodialysis system cleared specifically by the FDA for home hemodialysis and home nocturnal hemodialysis. Its simplicity and revolutionary size (just over a foot tall) are intended to allow convenient use in patients' homes and give patients the freedom to travel with their therapy. When combined with the NxStage PureFlow SL Dialysis Preparation System, patients are able to further simplify, using ordinary tap water to create dialysis fluid on demand. Unlike conventional hemodialysis systems, the System One requires no special infrastructure to operate. Under the guidance of their physician, patients can use the NxStage System One, with their trained partners, where, how and when it best meets their needs, including while they are sleeping - at home or on vacation and at a medically appropriate treatment frequency. http://www.nxstage.com/.
About NxStage Medical
NxStage Medical Inc. (Nasdaq: NXTM) is a medical device company, headquartered in Lawrence, Massachusetts, USA, that develops, manufactures and markets innovative products for the treatment of ESRD and acute kidney failure. For more information on NxStage and its products, please visit the Company's website at www.nxstage.com.
This release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this release that are not clearly historical in nature are forward-looking, and the words "anticipate," "believe," "expect," "estimate," "plan," and similar expressions are generally intended to identify forward-looking statements. Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors including those that are discussed in NxStage's filings with the Securities and Exchange Commission, including the Quarterly Report on Form 10-Q for the quarter ended March 31, 2015. NxStage is under no obligation to (and expressly disclaims any such obligation to) update or alter its forward-looking statements, whether as a result of new information, future events or otherwise.
Kristen K. Sheppard, Esq.
SOURCE NxStage Medical, Inc.